Mitochondrial optic neuropathies: our travels from bench to bedside and back again

被引:41
|
作者
Sadun, Alfredo A. [1 ]
La Morgia, Chiara [2 ,3 ]
Carelli, Valerio [1 ,2 ,3 ]
机构
[1] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA
[2] Univ Bologna, Bellaria Hosp, Neurol Unit, IRCCS Ist Sci Neurol, Bologna, Italy
[3] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie DiBiNeM, Bologna, Italy
来源
关键词
Leber's hereditary optic neuropathy; mitochondria; optic nerve; ASYMPTOMATIC CARRIERS; IDEBENONE TREATMENT; DNA; MUTATION; DYSFUNCTION; ATROPHY; DEATH; OPA1; NEURODEGENERATION; PEDIGREE;
D O I
10.1111/ceo.12086
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The standard scientific method requires that you make an interesting observation, generate a hypothesis and then design an experiment to test the hypothesis. In ophthalmology, as in most fields of medicine, the observations and hypotheses tend to have more degrees of freedom, and the interpretation of experiments is also more complicated and often indeterminate. But sometimes it works out, going back and forth from bench to bedside to bench, in reiterative cycles. A successful example of alternating bench and bedside studies was presented (AAS) at the 2012 Alper Memorial given at the Washington Hospital Medical Center, illustrating a series of questions and investigations that pertain to mitochondrial optic neuropathies, beginning two decades ago, before the concept of mitochondrial optic neuropathies had much meaning. Basic science questions are often best answered by that extraordinary experiment of nature that we call clinical disease, and clinical questions are often best tested in the laboratory.
引用
收藏
页码:702 / 712
页数:11
相关论文
共 50 条
  • [31] From Bedside to Bench and Back Again: Technology Innovation in Plastic Surgery
    Gurtner, Geoffrey C.
    Rohrich, Rod J.
    Longaker, Michael T.
    PLASTIC AND RECONSTRUCTIVE SURGERY, 2009, 124 (04) : 1355 - 1356
  • [32] Reserve Mechanisms in Neurodegenerative Diseases: From Bench to Bedside and Back Again
    Borroni, B.
    Premi, E.
    Bozzali, M.
    Padovani, A.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (36) : 6112 - 6118
  • [33] Insights From Atrial Fibrillation Genomics From Bedside to Bench and Back Again
    Chung, Mina K.
    Wass, So Jin Youn
    Barnard, John
    CARDIOLOGY IN REVIEW, 2019, 27 (06) : 302 - 307
  • [34] Bringing It All Together Bedside to Bench and Back Again
    James, Jeanne
    Robbins, Jeffrey
    CIRCULATION RESEARCH, 2015, 117 (12) : 987 - 989
  • [35] In vivo confocal microscopy of the ocular surface: from bench to bedside and back again
    Zhivov, Andrey
    Guthoff, Rudolf F.
    Stachs, Oliver
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (12) : 1557 - 1558
  • [36] From bedside to bench and back
    De Herdt, Veerle
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 (11) : 3547 - 3547
  • [37] Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again
    Plano, Federica
    Corsale, Anna Maria
    Gigliotta, Emilia
    Camarda, Giulia
    Vullo, Candida
    Di Simone, Marta
    Azgomi, Mojtaba Shekarkar
    Speciale, Maria
    Carlisi, Melania
    Caccamo, Nadia
    Dieli, Francesco
    Meraviglia, Serena
    Siragusa, Sergio
    Botta, Cirino
    HEMATOLOGY REPORTS, 2023, 15 (01) : 23 - 49
  • [38] Induced Pluripotent Stem Cells: From the Bedside to the Bench, and Hopefully Back Again
    Van Driest, Sara L.
    van der Graaf, Piet H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (02) : 173 - 175
  • [39] From bedside to bench and back again - molecular mechanisms in acute liver failure
    Pandol, Stephen J.
    FRONTIERS IN PHYSIOLOGY, 2014, 5
  • [40] Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again?
    Saleh, R. R.
    Bouganim, N.
    Hilton, J.
    Arnaout, A.
    Clemons, M.
    CURRENT ONCOLOGY, 2014, 21 (01) : E122 - E128